ArticleEuropean journal of clinical pharmacology2016

Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient.

Dario Cattaneo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.